Covered recipient · General Payments record
YESENIA VALDEZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2019
$403.19
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $153.98 | 10 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $27.82 | 2 |
| PFIZER INC. | $25.95 | 1 |
| Alkermes, Inc. | $22.52 | 1 |
| Amgen Inc. | $14.40 | 1 |
| Sunovion Pharmaceuticals Inc. | $14.22 | 1 |
| Acerta Pharma LLC | $13.06 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $12.45 | 1 |
| Orexo US, Inc. | $12.44 | 1 |
| GlaxoSmithKline, LLC. | $11.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $22.52 | 03/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | 686636875 | CMS |
| Amgen Inc. | $14.40 | 02/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663192649 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.06 | 03/27/2019 | Food and Beverage | Undisputed | 01/23/2026 | 685558543 | CMS |
| GlaxoSmithKline, LLC. | $11.12 | 06/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671540357 | CMS |
| Ironshore Pharmaceuticals Inc. | $12.45 | 07/09/2019 | Food and Beverage | Undisputed | 01/23/2026 | 707573695 | CMS |
| Lilly USA, LLC | $12.80 | 01/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658227637 | CMS |
| Lilly USA, LLC | $15.02 | 04/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | 658220831 | CMS |
| Orexo US, Inc. | $12.44 | 02/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 701222353 | CMS |
| PFIZER INC. | $25.95 | 01/03/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672198443 | CMS |
| Sunovion Pharmaceuticals Inc. | $14.22 | 05/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | 687961611 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.